Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zactima + Docetaxel in HRPC
NCT00498797Phase 2Completed
- Sponsor
- Sanofi
- Start
- Dec 2005
- Primary completion
- Jul 2007
- Modality
- Small Molecules
- Countries
- 5
01
Overview
A Phase 2 trial of vandetanib in prostate cancer (PCa), sponsored by Sanofi. Started Dec 2005; status: completed.
02
Drugs
vandetanib
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT00498797.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00498797.